BG - Bunge Limited (Daily chart, NYSE) - Long Position; short-term research idea.
Risk assessment: Medium {support structure integrity risk}
Risk/Reward ratio ~ 3
Current Market Price (CMP) ~ 75.80
Entry limit ~ 75.50 to 74.50 (Avg. - 75) on April 15, 2025
Target limit ~ 78 (+4%; +3 points)
Stop order limit ~ 74 (-1.33%; -1 point)
Disclaimer: Investments in securities markets are subject to market risks. All information presented in this group is strictly for reference and personal study purposes only and is not a recommendation and/or a solicitation to act upon under any interpretation of the letter.
LEGEND:
{curly brackets} = observation notes
[square brackets] = important updates
(parentheses) = information details
~ tilde/approximation = variable value
-hyphen = fixed value
Risk assessment: Medium {support structure integrity risk}
Risk/Reward ratio ~ 3
Current Market Price (CMP) ~ 75.80
Entry limit ~ 75.50 to 74.50 (Avg. - 75) on April 15, 2025
Target limit ~ 78 (+4%; +3 points)
Stop order limit ~ 74 (-1.33%; -1 point)
Disclaimer: Investments in securities markets are subject to market risks. All information presented in this group is strictly for reference and personal study purposes only and is not a recommendation and/or a solicitation to act upon under any interpretation of the letter.
LEGEND:
{curly brackets} = observation notes
[square brackets] = important updates
(parentheses) = information details
~ tilde/approximation = variable value
-hyphen = fixed value
Order cancelled
[UPDATE] - Research idea inapplicable; EXPIRED.BG - Bunge Limited (Daily chart, NYSE) - Long Position.
Entry limit ~ 75.50 to 74.50 (Avg. - 75) on April 15, 2025
Target limit ~ 78 (+4%; +3 points)
Stop order limit ~ 74 (-1.33%; -1 point)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.